Papers by Lixin Guo
16 results
- Aging Medicine (Milton (N.S.W))
Expert Consensus on the Management of Obesity in Older Adults (2026 Edition)
CommentaryIndustry & policy - Diabetes Research and Clinical Practice
The impact of new obesity definitions on prevalence and health outcomes
Cohort study of 498,353 peoplePopulations - Healthcare
Two-Time-Point Inflammatory Status Patterns and the Risk of Incident Diabetes: A Cohort Study Based on CHARLS
Cohort study of 4,305 peopleType 2 diabetes
- The Lancet Diabetes & Endocrinology
Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
Randomised trial in 242 peopleSemaglutide - ADA Scientific Sessions 2026 Abstract
Prevalence and Clinical Characteristics of MASLD in China: A Real-World Analysis Using the Meinian Health Checkup Database
Study in peoplePopulations - ADA Scientific Sessions 2026 Abstract
Effect of Subcutaneous Semaglutide on Cardiorenal Outcomes across Type 2 Diabetes Subtypes: SUSTAIN 6 Post Hoc Analysis
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Dual GLP-1R/GCGR Activation Reprograms Systemic and Hepatic Metabolism to Ameliorate MAFLD
Experiments in animalsInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy of Antiobesity Agents on Fat Distribution—A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
ReviewInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of HDG1901 vs. Ozempic in Patients with Type 2 Diabetes (T2D)—A Randomized, Open-Label, Bioequivalence Phase 3 Trial
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of a Novel Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist (HRS-7535) in Type 2 Diabetes Mellitus Patients Inadequately Controlled by Metformin
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of Tirzepatide Added to Basal Insulin in Chinese Patients with Type 2 Diabetes (SURPASS-CN-INS)
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
The Association between Glycemic Control, Normal Weight, and Long-Term Macrovascular Outcomes in People with T2D in China
Study in peoplePopulations - ADA Scientific Sessions 2025 Abstract
Association between Body Roundness Index and Chronic Kidney Disease Risk in Diabetic Patients—Insights from NHANES 1999–2018
Study in peopleBiomarkers